United Therapeutic (UTHR)
$81.68 1.17 (1.41%)
13:30 EDT UTHR Stock Quote Delayed 15 Minutes
Previous Close $82.85
Market Cap 3.56B
PE Ratio 7.43
Volume (Avg. Vol.) 105,618
Day's Range 81.30 - 83.68
52-Week Range 74.31 - 129.59
Dividend & Yield N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeutic News
- From InvestorPlace
- From the Web
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
MannKind scored a collaboration deal with biotechnology giant, United Therapeutics. This development partnership could pay off big.
United Therapeutics (UTHR) shares skyrocketed Friday amidst rumors that the company may be the subject of a takeover by a pharma giant soon.
3D Systems is up more than 20% so far this year, but DDD stock needs a first-quarter earnings beat to keep the momentum rolling.
Why General Motors Company (GM), Acorda Therapeutics Inc (ACOR) and United Therapeutics Corporation (UTHR) Are 3 of Today’s Worst Stocks
Acorda Therapeutics (ACOR), General Motors (GM) and United Therapeutics (UTHR) investors ended up wishing last weekend was a three-day weekend.
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Healthcare stocks finished up 0.3% on Wall Street on Thursday.
Healthcare stocks finished up 1.5% on Wall Street on Wednesday.
Healthcare stocks finished up 0.3% on Wall Street today.
Healthcare stocks rose 0.8% on Wall Street on Wednesday morning.
Healthcare stocks declined broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks declined 1.9% on Wall Street today.
From Market News Video
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component United Therapeutics Corp (UTHR) was identified as having a larger market cap than the smaller end of the S&P 500, for example Nektar Therapeutics (NKTR), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..
From Smarter Analyst
From Analyst Ratings
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics (UTHR – Research Report), with a price target of $273. The company’s shares opened today at $81.29, close to its 52-week low of $74.31. According to TipRanks.com, Moussatos has 0 stars on 0-5 star ranking scale with an average
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!